EvaluatingExtracorporeal Membrane Oxygenationand Ventilation Treatment of Patients with COVID-19: A Review

The prevalence of COVID-19 in the world is rapidly increasing.Although some patients show mild symptoms of the virus, some others need special care due to the exacerbation of the disease. Therefore, invasive treatments are needed to treat these patients. Data were collected from PubMedand Google scholars at varioustime points up to the 2020 academic year. The related keywords are listed as follows: "COVID-19", "Treatment", "Pathogenesis", and "Lung disorder". Studies have shown that although the use of ECMO and ventilation can provide oxygen to patients and improvetheir clinical status; these procedures can lead to the activation of inflammatory responses and the activation of the renin-angiotensin system. Inflammation and activation of the renin-angiotensin system are among the weak prognoses for COVID-19-infectedpatients. ECMO and ventilation treatment procedures are like double-edged swords, and monitoring patients during treatment is essential to prevent renin-angiotensin activation.